DCTPP1, an Oncogene Regulated by miR-378a-3p, Promotes Proliferation of Breast Cancer via DNA Repair Signaling Pathway.

Frontiers in Oncology
Ming NiuGuo-Qiang Zhang

Abstract

Breast cancer (BRCA) is one of the most deadly cancers worldwide, with poor survival rates that could be due to its high proliferation. Human all-alpha dCTP pyrophosphatase 1 (DCTPP1) is implicated in numerous diseases, including cancers. However, its role in BRCA is unclear. In this study, we used bioinformatic analyses of the ONCOMINE, UALCAN, and GEPIA databases to determine the expression pattern of DCTPP1 in BRCA. We found that elevated DCTPP1 levels correlate with poor BRCA prognosis. DCTPP1 silencing inhibited BRCA cell proliferation and induced apoptosis in vitro, as well as in vivo. Our data show that this tumorigenic effect depends on DNA repair signaling. Moreover, we found that DCTPP1 is directly modulated by miR-378a-3p, whose downregulation is linked to BRCA progression. Our results showed down-regulation of miR-378a-3p in BRCA. Upregulation of miR-378a-3p, on the other hand, can inhibit BRCA cell growth and proliferation. This study shows that reduced miR-378a-3p level enhances DCTPP1 expression in BRCA, which promotes proliferation by activating DNA repair signaling in BRCA.

References

Oct 3, 2013·European Journal of Histochemistry : EJH·Y ZhangY Wang
Dec 6, 2016·Pharmacology & Therapeutics·Farah J NassarRabih Talhouk
May 10, 2017·Environmental and Molecular Mutagenesis·Nimrat Chatterjee, Graham C Walker
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhi-Hong XuWei Liu
Aug 5, 2019·Cellular and Molecular Life Sciences : CMLS·Blanca Martínez-ArribasDolores González-Pacanowska
Aug 10, 2019·International Journal of Molecular Sciences·Qingqing LiuJianping Chen
Oct 11, 2019·Cells·Mohammad Mijanur RahmanTrygve O Tollefsbol
Nov 7, 2019·Cells·Ivana Fridrichova, Iveta Zmetakova
Jan 19, 2020·Journal of Molecular Biology·Emma ScalettiPål Stenmark
Feb 18, 2020·British Journal of Haematology·Stephanie JordaensBarbara-Ann Guinn
Apr 1, 2020·Journal of Cellular and Molecular Medicine·Lizhe ZhuBin Wang
Apr 11, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Junjie LiUNKNOWN CBCSG010 Study Group
May 6, 2020·The Journal of Gene Medicine·Yan ZhangLei Li
Jun 18, 2020·Journal of Cellular and Molecular Medicine·Qi ZhangYing Lin
Jun 21, 2020·International Journal of Molecular Sciences·Adriana GibadulinovaEliska Svastova
Jun 27, 2020·Cell Death and Differentiation·Dan WangRunsheng Chen
Jun 27, 2020·Frontiers in Oncology·Rainer W J KaiserRoman-Ulrich Müller
Jan 25, 2021·Journal of Experimental & Clinical Cancer Research : CR·Fangyu ChenXinchen Sun

❮ Previous
Next ❯

Software Mentioned

TargetScan
PITA
BioGrid
OmniPath
IM
Metascape
UALCAN
InWeb
GEPIA

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Journal of Insurance Medicine
M L Engman, C A Pinkham
Lijec̆nic̆ki vjesnik
S Habibović, Z Hrgović
Obstetrics and Gynecology
© 2021 Meta ULC. All rights reserved